Pneumococcal Vaccination is a Challenge of Pediatric Allergists

BAKIRTAS, ARZU; Ertoy Karagol, Hacer Ilbilge; Polat Terece, Sinem

doi:10.21911/aai.011

Pneumococcal Vaccination is a Challenge of Pediatric Allergists

Sinem POLAT, (Gazi Üniversitesi, Tıp Fakültesi, Pediatrik Allerji Anabilim Dalı, Ankara, Türkiye)

Hacer Ilbilge Ertoy KARAGOL, (Gazi Üniversitesi, Tıp Fakültesi, Pediatrik Allerji Anabilim Dalı, Ankara, Türkiye)

Arzu BAKIRTAŞ (Gazi Üniversitesi, Tıp Fakültesi, Pediatrik Allerji Anabilim Dalı, Ankara, Türkiye)

Astım Allerji İmmünoloji

1 0

Yıl: 2022 Cilt: 20 Sayı: 3 Sayfa Aralığı: 179 - 183 Metin Dili: İngilizce DOI: 10.21911/aai.011 İndeks Tarihi: 03-05-2023

Pneumococcal Vaccination is a Challenge of Pediatric Allergists

Öz:

Objective: An increased risk of invasive pneumococcal disease (IPD) has been reported in children with asthma before the introduction of pneumococcal vaccines (PVs). However, the evidence is limited after PV entered the routine immunization schedule. We aimed to investigate whether pediatric allergists recommend additional PV (aPV) to asthmatic children and if so whether there are any asthmaspecific risk factors they consider. We also wanted to determine any changes in their recommendations during the COVID-19 pandemic. Materials and Methods: A questionnaire was e-mailed to all members of the Academy of Pediatric Allergy and Asthma in Turkey. The questionnaire was filled online and consisted of 14 questions. Results: The questionnaire was e-mailed to 220 members. The response rate was 56.3% and 60.5% of PA recommended aPV. The most frequent asthma specific factors for aPV were severe asthma (70.2%), long term oral corticosteroid use (65.3%) and frequent exacerbations / hospitalizations (62.9%). COVID-19 pandemic increased the rate of questions asked to PA about aPV for asthmatic children compared to previous periods (75.8 vs 33.9%) (p<0.001) and %27 of PA changed their recommendations in favor of aPV during pandemic. Conclusion: Asthmatic children is not infrequent. Severe asthma and related factors seem to be the leading reasons to recommend aPV for asthmatic children. The aPV recommendation by PA is increased during COVID-19 pandemic.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Tan TQ. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev 2012;25:409-19.
2. Kaplan SL, Mason EO Jr, Wald E, Tan TQ, Schutze GE, Bradley JS, et al. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J 2002;21:141-7.
3. Beasley R, Semprini A, Mitchell EA. Risk factors for asthma: Is prevention possible? Lancet 2015;386:1075-85.
4. Castro-Rodriguez JA, Abarca K, Forno E. Asthma and the risk of invasive pneumococcal disease: A meta-analysis. Pediatrics 2020;145:e20191200.
5. Nuorti JP, Whitney CG; Centers for Disease Control and Prevention (CDC). Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010;59(RR-11):1-18.
6. American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: Use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics 2010;126(1):186- 90.
7. Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 2005;352:2082-90.
8. Pelton SI, Weycker D, Farkouh RA, Strutton DR, Shea KM, Edelsberg J. Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine. Clin Infect Dis 2014;59:615-23.
9. Qian CJ, Coulombe J, Suissa S, Ernst P. Pneumonia risk in asthma patients using inhaled corticosteroids: A quasi-cohort study. Br J Clin Pharmacol 2017;83:2077-86.
10. Papadopoulos NG, Custovic A, Deschildre A, Mathioudakis AG, Phipatanakul W, Wong G, et al. Impact of COVID-19 on pediatric asthma: Practice adjustments and disease burden. J Allergy Clin Immunol Pract 2020;8:2592-99.
11. Papadopoulos NG, Mathioudakis AG, Custovic A, Deschildre A, Phipatanakul W, Wong G, et al. Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort. Allergy 2021;76:1765-75.
12. Danino D, Ben-Shimol S, Van Der Beek BA, Givon-Lavi N, Avni YS, Greenberg D, et al. Decline in pneumococcal disease in young children during the COVID-19 pandemic in Israel associated with suppression of seasonal respiratory viruses, despite persistent pneumococcal carriage: A prospective cohort study. Clin Infect Dis 2022;75(1):e1154-64.
13. Amin-Chowdhury Z, Aiano F, Mensah A, Sheppard CL, Litt D, Fry NK, et al. Impact of the coronavirus disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Prospective national cohort study, England. Clin Infect Dis 2021;72:65-75.
14. Turner PJ, Larson H, Dubé È, Fisher A. Vaccine hesitancy: Drivers and how the allergy community can help. J Allergy Clin Immunol Pract 2021;9:3568-74.

APA	Polat Terece S, Ertoy Karagol H, BAKIRTAS A (2022). Pneumococcal Vaccination is a Challenge of Pediatric Allergists. , 179 - 183. 10.21911/aai.011
Chicago	Polat Terece Sinem,Ertoy Karagol Hacer Ilbilge,BAKIRTAS ARZU Pneumococcal Vaccination is a Challenge of Pediatric Allergists. (2022): 179 - 183. 10.21911/aai.011
MLA	Polat Terece Sinem,Ertoy Karagol Hacer Ilbilge,BAKIRTAS ARZU Pneumococcal Vaccination is a Challenge of Pediatric Allergists. , 2022, ss.179 - 183. 10.21911/aai.011
AMA	Polat Terece S,Ertoy Karagol H,BAKIRTAS A Pneumococcal Vaccination is a Challenge of Pediatric Allergists. . 2022; 179 - 183. 10.21911/aai.011
Vancouver	Polat Terece S,Ertoy Karagol H,BAKIRTAS A Pneumococcal Vaccination is a Challenge of Pediatric Allergists. . 2022; 179 - 183. 10.21911/aai.011
IEEE	Polat Terece S,Ertoy Karagol H,BAKIRTAS A "Pneumococcal Vaccination is a Challenge of Pediatric Allergists." , ss.179 - 183, 2022. 10.21911/aai.011
ISNAD	Polat Terece, Sinem vd. "Pneumococcal Vaccination is a Challenge of Pediatric Allergists". (2022), 179-183. https://doi.org/10.21911/aai.011

APA	Polat Terece S, Ertoy Karagol H, BAKIRTAS A (2022). Pneumococcal Vaccination is a Challenge of Pediatric Allergists. Astım Allerji İmmünoloji, 20(3), 179 - 183. 10.21911/aai.011
Chicago	Polat Terece Sinem,Ertoy Karagol Hacer Ilbilge,BAKIRTAS ARZU Pneumococcal Vaccination is a Challenge of Pediatric Allergists. Astım Allerji İmmünoloji 20, no.3 (2022): 179 - 183. 10.21911/aai.011
MLA	Polat Terece Sinem,Ertoy Karagol Hacer Ilbilge,BAKIRTAS ARZU Pneumococcal Vaccination is a Challenge of Pediatric Allergists. Astım Allerji İmmünoloji, vol.20, no.3, 2022, ss.179 - 183. 10.21911/aai.011
AMA	Polat Terece S,Ertoy Karagol H,BAKIRTAS A Pneumococcal Vaccination is a Challenge of Pediatric Allergists. Astım Allerji İmmünoloji. 2022; 20(3): 179 - 183. 10.21911/aai.011
Vancouver	Polat Terece S,Ertoy Karagol H,BAKIRTAS A Pneumococcal Vaccination is a Challenge of Pediatric Allergists. Astım Allerji İmmünoloji. 2022; 20(3): 179 - 183. 10.21911/aai.011
IEEE	Polat Terece S,Ertoy Karagol H,BAKIRTAS A "Pneumococcal Vaccination is a Challenge of Pediatric Allergists." Astım Allerji İmmünoloji, 20, ss.179 - 183, 2022. 10.21911/aai.011
ISNAD	Polat Terece, Sinem vd. "Pneumococcal Vaccination is a Challenge of Pediatric Allergists". Astım Allerji İmmünoloji 20/3 (2022), 179-183. https://doi.org/10.21911/aai.011